> 0 1 0 1 O
4 2 3 2 3 B-lower_bound
weeks 4 9 4 9 I-lower_bound
from 10 14 10 14 O
prior 15 20 15 20 B-treatment
therapy 21 28 21 28 I-treatment
completion 29 39 29 39 O
( 40 41 40 41 O
including 41 50 41 50 O
radiation 51 60 51 60 B-treatment
and/or 61 67 61 67 O
surgery 68 75 68 75 B-treatment
) 75 76 75 76 O

Able 0 4 77 81 O
to 5 7 82 84 O
swallow 8 15 85 92 O
and 16 19 93 96 O
retain 20 26 97 103 O
oral 27 31 104 108 B-treatment
medication 32 42 109 119 I-treatment

Absolute 0 8 120 128 B-clinical_variable
neutrophil 9 19 129 139 I-clinical_variable
count 20 25 140 145 I-clinical_variable
( 26 27 146 147 I-clinical_variable
ANC 27 30 147 150 I-clinical_variable
) 30 31 150 151 I-clinical_variable
> 32 33 152 153 O
= 33 34 153 154 O
1.5 35 38 155 158 B-lower_bound
x 39 40 159 160 I-lower_bound
10 41 43 161 163 I-lower_bound
^ 43 44 163 164 I-lower_bound
9 44 45 164 165 I-lower_bound
/ 45 46 165 166 I-lower_bound
L 46 47 166 167 I-lower_bound

Alanine 0 7 168 175 B-clinical_variable
transaminase 8 20 176 188 I-clinical_variable
( 21 22 189 190 I-clinical_variable
alanine 22 29 190 197 I-clinical_variable
aminotransferase 30 46 198 214 I-clinical_variable
[ 47 48 215 216 I-clinical_variable
ALT 48 51 216 219 I-clinical_variable
] 51 52 219 220 I-clinical_variable
) 52 53 220 221 I-clinical_variable
= 54 55 222 223 O
< 55 56 223 224 O
2 57 58 225 226 B-upper_bound
x 59 60 227 228 I-upper_bound
upper 61 66 229 234 I-upper_bound
normal 67 73 235 241 I-upper_bound
limit 74 79 242 247 I-upper_bound
( 80 81 248 249 I-upper_bound
ULN 81 84 249 252 I-upper_bound
) 84 85 252 253 I-upper_bound
( 86 87 254 255 O
in 87 89 255 257 O
the 90 93 258 261 O
expansion 94 103 262 271 O
cohort 104 110 272 278 O
, 110 111 278 279 O
patients 112 120 280 288 O
with 121 125 289 293 O
known 126 131 294 299 O
liver 132 137 300 305 O
involvement 138 149 306 317 O
may 150 153 318 321 O
have 154 158 322 326 O
ALT 159 162 327 330 O
= 163 164 331 332 O
< 164 165 332 333 O
5 166 167 334 335 B-upper_bound
x 168 169 336 337 I-upper_bound
ULN 170 173 338 341 I-upper_bound
) 173 174 341 342 O

Albumin 0 7 343 350 B-clinical_variable
> 8 9 351 352 O
= 9 10 352 353 O
3 11 12 354 355 B-lower_bound
g 13 14 356 357 I-lower_bound
/ 14 15 357 358 I-lower_bound
dL 15 17 358 360 I-lower_bound

Alkaline 0 8 361 369 B-clinical_variable
phosphatase 9 20 370 381 I-clinical_variable
< 21 22 382 383 O
4 23 24 384 385 B-upper_bound
x 25 26 386 387 I-upper_bound
ULN 27 30 388 391 I-upper_bound

Allergic 0 8 392 400 O
to 9 11 401 403 O
selinexor 12 21 404 413 B-allergy_name
or 22 24 414 416 O
any 25 28 417 420 O
of 29 31 421 423 O
the 32 35 424 427 O
chemotherapy 36 48 428 440 B-treatment
intended 49 57 441 449 O
to 58 60 450 452 O
receive 61 68 453 460 O

Chemotherapy 0 12 461 473 B-treatment
, 12 13 473 474 O
or 14 16 475 477 O
immunotherapy 17 30 478 491 B-treatment
or 31 33 492 494 O
any 34 37 495 498 O
other 38 43 499 504 O
systemic 44 52 505 513 B-treatment
anticancer 53 63 514 524 I-treatment
therapy 64 71 525 532 I-treatment
= 72 73 533 534 O
< 73 74 534 535 O
3 75 76 536 537 B-upper_bound
weeks 77 82 538 543 I-upper_bound
prior 83 88 544 549 I-upper_bound
to 89 91 550 552 O
study 92 97 553 558 B-treatment
drug 98 102 559 563 I-treatment
administration 103 117 564 578 O
date 118 122 579 583 O
; 122 123 583 584 O
patients 124 132 585 593 O
receiving 133 142 594 603 O
anti 143 147 604 608 B-treatment
- 147 148 608 609 I-treatment
PD-1 148 152 609 613 I-treatment
treatment 153 162 614 623 I-treatment
, 162 163 623 624 O
and 164 167 625 628 O
continue 168 176 629 637 O
to 177 179 638 640 O
receiving 180 189 641 650 O
this 190 194 651 655 O
treatment 195 204 656 665 O
in 205 207 666 668 O
combination 208 219 669 680 O
with 220 224 681 685 O
selinexor 225 234 686 695 B-treatment
( 235 236 696 697 O
Arms 236 240 697 701 O
L 241 242 702 703 O
and 243 246 704 707 O
M 247 248 708 709 O
) 248 249 709 710 O
, 249 250 710 711 O
can 251 254 712 715 O
start 255 260 716 721 O
receiving 261 270 722 731 O
the 271 274 732 735 O
selinexor 275 284 736 745 O
and 285 288 746 749 O
anti 289 293 750 754 B-treatment
- 293 294 754 755 I-treatment
PD-1 294 298 755 759 I-treatment
combination 299 310 760 771 I-treatment
without 311 318 772 779 O
washout 319 326 780 787 O
of 327 329 788 790 O
the 330 333 791 794 O
prior 334 339 795 800 B-treatment
anti 340 344 801 805 I-treatment
- 344 345 805 806 I-treatment
PD-1 345 349 806 810 I-treatment
antibody 350 358 811 819 I-treatment

Clinically 0 10 820 830 O
stable 11 17 831 837 O
with 18 22 838 842 O
respect 23 30 843 850 O
to 31 33 851 853 O
the 34 37 854 857 O
CNS 38 41 858 861 B-cancer
tumor 42 47 862 867 I-cancer
at 48 50 868 870 O
the 51 54 871 874 O
time 55 59 875 879 O
of 60 62 880 882 O
study 63 68 883 888 O
entry 69 74 889 894 O

Concurrent 0 10 895 905 O
therapy 11 18 906 913 B-treatment
with 19 23 914 918 O
approved 24 32 919 927 O
or 33 35 928 930 O
investigational 36 51 931 946 B-treatment
anticancer 52 62 947 957 I-treatment
therapeutics 63 75 958 970 I-treatment

Diagnosis 0 9 971 980 O
or 10 12 981 983 O
recurrence 13 23 984 994 O
of 24 26 995 997 O
invasive 27 35 998 1006 B-cancer
cancer 36 42 1007 1013 I-cancer
other 43 48 1014 1019 O
than 49 53 1020 1024 O
the 54 57 1025 1028 O
present 58 65 1029 1036 O
cancer 66 72 1037 1043 O
within 73 79 1044 1050 O
3 80 81 1051 1052 B-upper_bound
years 82 87 1053 1058 I-upper_bound
( 88 89 1059 1060 O
except 89 95 1060 1066 O
basal 96 101 1067 1072 B-cancer
or 102 104 1073 1075 O
squamous 105 113 1076 1084 B-cancer
cell 114 118 1085 1089 I-cancer
carcinoma 119 128 1090 1099 I-cancer
of 129 131 1100 1102 I-cancer
the 132 135 1103 1106 I-cancer
skin 136 140 1107 1111 I-cancer
that 141 145 1112 1116 O
has 146 149 1117 1120 O
been 150 154 1121 1125 O
definitively 155 167 1126 1138 O
treated 168 175 1139 1146 O
) 175 176 1146 1147 O

Eastern 0 7 1148 1155 B-treatment
Cooperative 8 19 1156 1167 I-treatment
Oncology 20 28 1168 1176 I-treatment
Group 29 34 1177 1182 I-treatment
( 35 36 1183 1184 I-treatment
ECOG 36 40 1184 1188 I-treatment
) 40 41 1188 1189 I-treatment
performance 42 53 1190 1201 I-treatment
status 54 60 1202 1208 I-treatment
of 61 63 1209 1211 O
0 64 65 1212 1213 B-lower_bound
- 65 66 1213 1214 O
1 66 67 1214 1215 B-upper_bound

Evidence 0 8 1216 1224 O
of 9 11 1225 1227 O
complete 12 20 1228 1236 O
or 21 23 1237 1239 O
partial 24 31 1240 1247 O
bowel 32 37 1248 1253 B-chronic_disease
obstruction 38 49 1254 1265 I-chronic_disease

For 0 3 1266 1269 O
Arm 4 7 1270 1273 O
K 8 9 1274 1275 O
( 10 11 1276 1277 O
olaparib 11 19 1277 1285 B-treatment
) 19 20 1285 1286 O
, 20 21 1286 1287 O
patients 22 30 1288 1296 O
must 31 35 1297 1301 O
have 36 40 1302 1306 O
pre 41 44 1307 1310 O
- 44 45 1310 1311 O
identified 45 55 1311 1321 O
BRCA 56 60 1322 1326 B-cancer
mutant 61 67 1327 1333 I-cancer
cancer 68 74 1334 1340 I-cancer

For 0 3 1341 1344 O
the 4 7 1345 1348 O
Arm 8 11 1349 1352 O
B 12 13 1353 1354 O
( 14 15 1355 1356 O
paclitaxel 15 25 1356 1366 O
) 25 26 1366 1367 O
expansion 27 36 1368 1377 O
cohort 37 43 1378 1384 O
, 43 44 1384 1385 O
patients 45 53 1386 1394 O
must 54 58 1395 1399 O
have 59 63 1400 1404 O
ovarian 64 71 1405 1412 O
carcinoma 72 81 1413 1422 B-cancer

Hemoglobin 0 10 1423 1433 B-clinical_variable
> 11 12 1434 1435 O
= 12 13 1435 1436 O
10 14 16 1437 1439 B-lower_bound
g 17 18 1440 1441 I-lower_bound
/ 18 19 1441 1442 I-lower_bound
dL 19 21 1442 1444 I-lower_bound
( 22 23 1445 1446 O
for 23 26 1446 1449 O
Arm 27 30 1450 1453 O
L 31 32 1454 1455 O
pembrolizumab 33 46 1456 1469 B-treatment
and 47 50 1470 1473 O
Arm 51 54 1474 1477 O
M 55 56 1478 1479 O
nivolumab 57 66 1480 1489 B-treatment
and 67 70 1490 1493 O
expansion 71 80 1494 1503 O
cohorts 81 88 1504 1511 O
for 89 92 1512 1515 O
all 93 96 1516 1519 O
arms 97 101 1520 1524 O
, 101 102 1524 1525 O
hemoglobin 103 113 1526 1536 B-clinical_variable
> 114 115 1537 1538 O
= 115 116 1538 1539 O
9 117 118 1540 1541 B-lower_bound
g 119 120 1542 1543 I-lower_bound
/ 120 121 1543 1544 I-lower_bound
dL 121 123 1544 1546 I-lower_bound

Life 0 4 1547 1551 B-clinical_variable
expectancy 5 15 1552 1562 I-clinical_variable
of 16 18 1563 1565 O
at 19 21 1566 1568 O
least 22 27 1569 1574 O
12 28 30 1575 1577 B-lower_bound
weeks 31 36 1578 1583 I-lower_bound

Major 0 5 1584 1589 B-treatment
surgery 6 13 1590 1597 I-treatment
within 14 20 1598 1604 O
four 21 25 1605 1609 B-upper_bound
weeks 26 31 1610 1615 I-upper_bound
before 32 38 1616 1622 O
consent 39 46 1623 1630 O
date 47 51 1631 1635 O

Men 0 3 1636 1639 B-gender
whose 4 9 1640 1645 O
partner 10 17 1646 1653 O
is 18 20 1654 1656 O
a 21 22 1657 1658 O
woman 23 28 1659 1664 B-gender
of 29 31 1665 1667 O
child 32 37 1668 1673 O
- 37 38 1673 1674 O
bearing 38 45 1674 1681 O
potential 46 55 1682 1691 O
, 55 56 1691 1692 O
( 57 58 1693 1694 O
i.e. 58 62 1694 1698 O
biologically 63 75 1699 1711 O
able 76 80 1712 1716 O
to 81 83 1717 1719 O
conceive 84 92 1720 1728 O
) 92 93 1728 1729 O
, 93 94 1729 1730 O
and 95 98 1731 1734 O
who 99 102 1735 1738 O
is 103 105 1739 1741 O
not 106 109 1742 1745 O
employing 110 119 1746 1755 O
two 120 123 1756 1759 O
forms 124 129 1760 1765 O
of 130 132 1766 1768 O
highly 133 139 1769 1775 O
effective 140 149 1776 1785 O
contraception 150 163 1786 1799 O

Negative 0 8 1800 1808 B-pregnancy
serum 9 14 1809 1814 I-pregnancy
pregnancy 15 24 1815 1824 I-pregnancy
test 25 29 1825 1829 O
in 30 32 1830 1832 O
women 33 38 1833 1838 B-gender
of 39 41 1839 1841 O
childbearing 42 54 1842 1854 O
potential 55 64 1855 1864 O
within 65 71 1865 1871 O
7 72 73 1872 1873 B-upper_bound
days 74 78 1874 1878 I-upper_bound
of 79 81 1879 1881 O
first 82 87 1882 1887 O
dose 88 92 1888 1892 O
of 93 95 1893 1895 O
treatment 96 105 1896 1905 B-treatment
and 106 109 1906 1909 O
patients 110 118 1910 1918 O
of 119 121 1919 1921 O
child 122 127 1922 1927 O
- 127 128 1927 1928 O
bearing 128 135 1928 1935 O
potential 136 145 1936 1945 O
must 146 150 1946 1950 O
agree 151 156 1951 1956 B-contraception_consent
to 157 159 1957 1959 I-contraception_consent
use 160 163 1960 1963 I-contraception_consent
effective 164 173 1964 1973 I-contraception_consent
contraception 174 187 1974 1987 I-contraception_consent
during 188 194 1988 1994 O
/ 194 195 1994 1995 O
after 195 200 1995 2000 B-upper_bound
3 201 202 2001 2002 I-upper_bound
months 203 209 2003 2009 I-upper_bound
post 210 214 2010 2014 O
dose 215 219 2015 2019 O

Not 0 3 2020 2023 O
receiving 4 13 2024 2033 O
anti 14 18 2034 2038 B-treatment
- 18 19 2038 2039 I-treatment
convulsive 19 29 2039 2049 I-treatment
medications 30 41 2050 2061 I-treatment
( 42 43 2062 2063 O
that 43 47 2063 2067 O
were 48 52 2068 2072 O
started 53 60 2073 2080 O
for 61 64 2081 2084 O
brain 65 70 2085 2090 B-cancer
metastases 71 81 2091 2101 I-cancer
) 81 82 2101 2102 O

Not 0 3 2103 2106 O
receiving 4 13 2107 2116 O
steroid 14 21 2117 2124 B-treatment
therapy 22 29 2125 2132 I-treatment
in 30 32 2133 2135 O
treating 33 41 2136 2144 O
CNS 42 45 2145 2148 B-cancer
tumor 46 51 2149 2154 I-cancer
or 52 54 2155 2157 O
CNS 55 58 2158 2161 O
tumor 59 64 2162 2167 O
involvement 65 76 2168 2179 O

Platelets 0 9 2180 2189 B-clinical_variable
> 10 11 2190 2191 O
= 11 12 2191 2192 O
125 13 16 2193 2196 B-lower_bound
x 17 18 2197 2198 I-lower_bound
10 19 21 2199 2201 I-lower_bound
^ 21 22 2201 2202 I-lower_bound
9 22 23 2202 2203 I-lower_bound
/ 23 24 2203 2204 I-lower_bound
L 24 25 2204 2205 I-lower_bound
( 26 27 2206 2207 O
for 27 30 2207 2210 O
Arm 31 34 2211 2214 O
L 35 36 2215 2216 O
pembrolizumab 37 50 2217 2230 B-treatment
and 51 54 2231 2234 O
Arm 55 58 2235 2238 O
M 59 60 2239 2240 O
nivolumab 61 70 2241 2250 B-treatment
and 71 74 2251 2254 O
expansion 75 84 2255 2264 O
cohorts 85 92 2265 2272 O
for 93 96 2273 2276 O
all 97 100 2277 2280 O
arms 101 105 2281 2285 O
, 105 106 2285 2286 O
platelets 107 116 2287 2296 B-clinical_variable
> 117 118 2297 2298 O
= 118 119 2298 2299 O
100 120 123 2300 2303 B-lower_bound
x 124 125 2304 2305 I-lower_bound
10 126 128 2306 2308 I-lower_bound
^ 128 129 2308 2309 I-lower_bound
9 129 130 2309 2310 I-lower_bound
/ 130 131 2310 2311 I-lower_bound
L 131 132 2311 2312 I-lower_bound
) 132 133 2312 2313 O

Pregnancy 0 9 2314 2323 B-pregnancy

Prior 0 5 2324 2329 B-treatment
treatment 6 15 2330 2339 I-treatment
with 16 20 2340 2344 I-treatment
an 21 23 2345 2347 I-treatment
agent 24 29 2348 2353 I-treatment
targeting 30 39 2354 2363 I-treatment
the 40 43 2364 2367 I-treatment
exportin 44 52 2368 2376 I-treatment

Radiation 0 9 2377 2386 B-treatment
( 10 11 2387 2388 O
except 11 17 2388 2394 O
planned 18 25 2395 2402 O
or 26 28 2403 2405 O
ongoing 29 36 2406 2413 O
palliative 37 47 2414 2424 B-treatment
radiation 48 57 2425 2434 I-treatment
to 58 60 2435 2437 O
bone 61 65 2438 2442 O
outside 66 73 2443 2450 O
of 74 76 2451 2453 O
the 77 80 2454 2457 O
region 81 87 2458 2464 O
of 88 90 2465 2467 O
measurable 91 101 2468 2478 O
disease 102 109 2479 2486 O
) 109 110 2486 2487 O
= 111 112 2488 2489 O
< 112 113 2489 2490 O
3 114 115 2491 2492 B-upper_bound
weeks 116 121 2493 2498 I-upper_bound
prior 122 127 2499 2504 I-upper_bound
to 128 130 2505 2507 O
study 131 136 2508 2513 B-treatment
drug 137 141 2514 2518 I-treatment
administration 142 156 2519 2533 O
date 157 161 2534 2538 O

Renal 0 5 2539 2544 O
function 6 14 2545 2553 O
defined 15 22 2554 2561 O
as 23 25 2562 2564 O
a 26 27 2565 2566 O
calculated 28 38 2567 2577 B-clinical_variable
or 39 41 2578 2580 I-clinical_variable
measured 42 50 2581 2589 I-clinical_variable
glomerular 51 61 2590 2600 I-clinical_variable
filtration 62 72 2601 2611 I-clinical_variable
rate 73 77 2612 2616 I-clinical_variable
( 78 79 2617 2618 I-clinical_variable
GFR 79 82 2618 2621 I-clinical_variable
) 82 83 2621 2622 I-clinical_variable
> 84 85 2623 2624 O
= 85 86 2624 2625 O
30 87 89 2626 2628 B-lower_bound
mL 90 92 2629 2631 I-lower_bound
/ 92 93 2631 2632 I-lower_bound
min 93 96 2632 2635 I-lower_bound

Significantly 0 13 2636 2649 O
diseased 14 22 2650 2658 O
( 23 24 2659 2660 O
as 24 26 2660 2662 O
determined 27 37 2663 2673 O
by 38 40 2674 2676 O
the 41 44 2677 2680 O
principal 45 54 2681 2690 O
investigator 55 67 2691 2703 O
[ 68 69 2704 2705 O
PI 69 71 2705 2707 O
] 71 72 2707 2708 O
or 73 75 2709 2711 O
treating 76 84 2712 2720 O
physician 85 94 2721 2730 O
) 94 95 2730 2731 O
or 96 98 2732 2734 O
obstructed 99 109 2735 2745 O
gastrointestinal 110 126 2746 2762 O
tract 127 132 2763 2768 O
or 133 135 2769 2771 O
uncontrolled 136 148 2772 2784 O
vomiting 149 157 2785 2793 B-chronic_disease
or 158 160 2794 2796 O
diarrhea 161 169 2797 2805 B-chronic_disease

Total 0 5 2806 2811 B-clinical_variable
bilirubin 6 15 2812 2821 I-clinical_variable
= 16 17 2822 2823 O
< 17 18 2823 2824 O
2 19 20 2825 2826 B-upper_bound
x 21 22 2827 2828 I-upper_bound
ULN 23 26 2829 2832 I-upper_bound
( 27 28 2833 2834 O
in 28 30 2834 2836 O
the 31 34 2837 2840 O
expansion 35 44 2841 2850 O
cohort 45 51 2851 2857 O
, 51 52 2857 2858 O
patients 53 61 2859 2867 O
with 62 66 2868 2872 O
Gilbert 67 74 2873 2880 B-chronic_disease
's 74 76 2880 2882 I-chronic_disease
syndrome 77 85 2883 2891 I-chronic_disease
[ 86 87 2892 2893 O
hereditary 87 97 2893 2903 O
indirect 98 106 2904 2912 O
hyperbilirubinemia 107 125 2913 2931 B-chronic_disease
] 125 126 2931 2932 O
who 127 130 2933 2936 O
must 131 135 2937 2941 O
have 136 140 2942 2946 O
a 141 142 2947 2948 O
total 143 148 2949 2954 B-clinical_variable
bilirubin 149 158 2955 2964 I-clinical_variable
of 159 161 2965 2967 O
= 162 163 2968 2969 O
< 163 164 2969 2970 O
3 165 166 2971 2972 B-upper_bound
x 167 168 2973 2974 I-upper_bound
ULN 169 172 2975 2978 I-upper_bound
) 172 173 2978 2979 O

Treatment 0 9 2980 2989 B-treatment
with 10 14 2990 2994 O
an 15 17 2995 2997 O
investigational 18 33 2998 3013 O
anti 34 38 3014 3018 B-treatment
- 38 39 3018 3019 I-treatment
cancer 39 45 3019 3025 I-treatment
study 46 51 3026 3031 I-treatment
drug 52 56 3032 3036 I-treatment
within 57 63 3037 3043 O
3 64 65 3044 3045 B-upper_bound
weeks 66 71 3046 3051 I-upper_bound
prior 72 77 3052 3057 I-upper_bound
to 78 80 3058 3060 O
study 81 86 3061 3066 O
drug 87 91 3067 3071 O
administration 92 106 3072 3086 O
date 107 111 3087 3091 O

Uncontrolled 0 12 3092 3104 B-chronic_disease
active 13 19 3105 3111 I-chronic_disease
infection 20 29 3112 3121 I-chronic_disease
requiring 30 39 3122 3131 O
parenteral 40 50 3132 3142 O
antibiotics 51 62 3143 3154 B-treatment
, 62 63 3154 3155 O
antivirals 64 74 3156 3166 B-treatment
, 74 75 3166 3167 O
or 76 78 3168 3170 O
antifungals 79 90 3171 3182 B-treatment
within 91 97 3183 3189 O
one 98 101 3190 3193 B-upper_bound
week 102 106 3194 3198 I-upper_bound
prior 107 112 3199 3204 I-upper_bound
to 113 115 3205 3207 O
the 116 119 3208 3211 O
first 120 125 3212 3217 O
dose 126 130 3218 3222 O

Unstable 0 8 3223 3231 O
cardiovascular 9 23 3232 3246 O
function 24 32 3247 3255 O
: 32 33 3255 3256 O
symptomatic 34 45 3257 3268 B-chronic_disease
ischemia 46 54 3269 3277 I-chronic_disease
( 55 56 3278 3279 O
chest 56 61 3279 3284 O
pain 62 66 3285 3289 O
of 67 69 3290 3292 O
cardiac 70 77 3293 3300 O
origin 78 84 3301 3307 O
) 84 85 3307 3308 O
, 85 86 3308 3309 O
or 87 89 3310 3312 O
uncontrolled 90 102 3313 3325 O
clinically 103 113 3326 3336 O
significant 114 125 3337 3348 O
conduction 126 136 3349 3359 O
abnormalities 137 150 3360 3373 O
( 151 152 3374 3375 O
e.g. 152 156 3375 3379 O
ventricular 157 168 3380 3391 B-chronic_disease
tachycardia 169 180 3392 3403 I-chronic_disease
on 181 183 3404 3406 O
antiarrhythmics 184 199 3407 3422 O
are 200 203 3423 3426 O
excluded 204 212 3427 3435 O
and 213 216 3436 3439 O
1st 217 220 3440 3443 B-chronic_disease
degree 221 227 3444 3450 I-chronic_disease
atrioventricular 228 244 3451 3467 I-chronic_disease
[ 245 246 3468 3469 I-chronic_disease
AV 246 248 3469 3471 I-chronic_disease
] 248 249 3471 3472 I-chronic_disease
block 250 255 3473 3478 I-chronic_disease
or 256 258 3479 3481 O
asymptomatic 259 271 3482 3494 B-chronic_disease
left 272 276 3495 3499 I-chronic_disease
anterior 277 285 3500 3508 I-chronic_disease
fascicular 286 296 3509 3519 I-chronic_disease
block 297 302 3520 3525 I-chronic_disease
[ 303 304 3526 3527 I-chronic_disease
LAFB]/right 304 315 3527 3538 I-chronic_disease
bundle 316 322 3539 3545 I-chronic_disease
branch 323 329 3546 3552 I-chronic_disease
block 330 335 3553 3558 I-chronic_disease
[ 336 337 3559 3560 I-chronic_disease
RBBB 337 341 3560 3564 I-chronic_disease
] 341 342 3564 3565 I-chronic_disease
will 343 347 3566 3570 O
not 348 351 3571 3574 O
be 352 354 3575 3577 O
excluded 355 363 3578 3586 O
) 363 364 3586 3587 O
, 364 365 3587 3588 O
or 366 368 3589 3591 O
congestive 369 379 3592 3602 B-chronic_disease
heart 380 385 3603 3608 I-chronic_disease
failure 386 393 3609 3616 I-chronic_disease
( 394 395 3617 3618 I-chronic_disease
CHF 395 398 3618 3621 I-chronic_disease
) 398 399 3621 3622 I-chronic_disease
of 400 402 3623 3625 O
New 403 406 3626 3629 B-clinical_variable
York 407 411 3630 3634 I-clinical_variable
Heart 412 417 3635 3640 I-clinical_variable
Association 418 429 3641 3652 I-clinical_variable
( 430 431 3653 3654 I-clinical_variable
NYHA 431 435 3654 3658 I-clinical_variable
) 435 436 3658 3659 I-clinical_variable
class 437 442 3660 3665 O
> 443 444 3666 3667 O
= 444 445 3667 3668 O
3 446 447 3669 3670 B-lower_bound
, 447 448 3670 3671 O
or 449 451 3672 3674 O
myocardial 452 462 3675 3685 B-chronic_disease
infarction 463 473 3686 3696 I-chronic_disease
( 474 475 3697 3698 I-chronic_disease
MI 475 477 3698 3700 I-chronic_disease
) 477 478 3700 3701 I-chronic_disease
within 479 485 3702 3708 O
3 486 487 3709 3710 B-upper_bound
months 488 494 3711 3717 I-upper_bound
of 495 497 3718 3720 O
consent 498 505 3721 3728 O
date 506 510 3729 3733 O

White 0 5 3734 3739 B-clinical_variable
blood 6 11 3740 3745 I-clinical_variable
cells 12 17 3746 3751 I-clinical_variable
( 18 19 3752 3753 I-clinical_variable
WBC 19 22 3753 3756 I-clinical_variable
) 22 23 3756 3757 I-clinical_variable
> 24 25 3758 3759 O
= 25 26 3759 3760 O
3 27 28 3761 3762 B-lower_bound
x 29 30 3763 3764 I-lower_bound
10 31 33 3765 3767 I-lower_bound
^ 33 34 3767 3768 I-lower_bound
9 34 35 3768 3769 I-lower_bound
/ 35 36 3769 3770 I-lower_bound
L 36 37 3770 3771 I-lower_bound
, 37 38 3771 3772 O
transfusions 39 51 3773 3785 O
and 52 55 3786 3789 O
growth 56 62 3790 3796 O
factors 63 70 3797 3804 O
are 71 74 3805 3808 O
allowed 75 82 3809 3816 O

active 0 6 3817 3823 B-chronic_disease
infection 7 16 3824 3833 I-chronic_disease
with 17 21 3834 3838 O
concurrent 22 32 3839 3849 B-treatment
treatment 33 42 3850 3859 I-treatment
is 43 45 3860 3862 O
acceptable 46 56 3863 3873 O
only 57 61 3874 3878 O
if 62 64 3879 3881 O
the 65 68 3882 3885 O
patient 69 76 3886 3893 O
is 77 79 3894 3896 O
clinically 80 90 3897 3907 O
stable 91 97 3908 3914 O

arms 0 4 3915 3919 O
except 5 11 3920 3926 O
Arm 12 15 3927 3930 O
L 16 17 3931 3932 O
( 18 19 3933 3934 O
pembrolizumab 19 32 3934 3947 B-treatment
) 32 33 3947 3948 O
and 34 37 3949 3952 O
Arm 38 41 3953 3956 O
M 42 43 3957 3958 O
( 44 45 3959 3960 O
nivolumab 45 54 3960 3969 B-treatment
) 54 55 3969 3970 O

aspartate 0 9 3971 3980 B-clinical_variable
aminotransferase 10 26 3981 3997 I-clinical_variable
( 27 28 3998 3999 I-clinical_variable
AST 28 31 3999 4002 I-clinical_variable
) 31 32 4002 4003 I-clinical_variable
= 33 34 4004 4005 O
< 34 35 4005 4006 O
2 36 37 4007 4008 B-upper_bound
x 38 39 4009 4010 I-upper_bound
ULN 40 43 4011 4014 I-upper_bound
( 44 45 4015 4016 O
in 45 47 4016 4018 O
the 48 51 4019 4022 O
expansion 52 61 4023 4032 O
cohort 62 68 4033 4039 O
, 68 69 4039 4040 O
patients 70 78 4041 4049 O
with 79 83 4050 4054 O
known 84 89 4055 4060 O
liver 90 95 4061 4066 O
involvement 96 107 4067 4078 O
may 108 111 4079 4082 O
have 112 116 4083 4087 O
AST 117 120 4088 4091 O
= 121 122 4092 4093 O
< 122 123 4093 4094 O
5 124 125 4095 4096 B-upper_bound
x 126 127 4097 4098 I-upper_bound
ULN 128 131 4099 4102 I-upper_bound
) 131 132 4102 4103 O

history 0 7 4104 4111 O
of 8 10 4112 4114 O
a 11 12 4115 4116 O
prior 13 18 4117 4122 B-chronic_disease
grade 19 24 4123 4128 I-chronic_disease
3 25 26 4129 4130 I-chronic_disease
or 27 29 4131 4133 I-chronic_disease
4 30 31 4134 4135 I-chronic_disease
immune 32 38 4136 4142 I-chronic_disease
- 38 39 4142 4143 I-chronic_disease
related 39 46 4143 4150 I-chronic_disease
adverse 47 54 4151 4158 I-chronic_disease
event 55 60 4159 4164 I-chronic_disease
( 61 62 4165 4166 I-chronic_disease
irAE 62 66 4166 4170 I-chronic_disease
) 66 67 4170 4171 I-chronic_disease
or 68 70 4172 4174 O
any 71 74 4175 4178 O
grade 75 80 4179 4184 O
ocular 81 87 4185 4191 O
irAE 88 92 4192 4196 O
from 93 97 4197 4201 O
prior 98 103 4202 4207 B-treatment
immunotherapy 104 117 4208 4221 I-treatment

metastatic 0 10 4222 4232 B-cancer
CNS 11 14 4233 4236 I-cancer
tumors 15 21 4237 4243 I-cancer
may 22 25 4244 4247 O
participate 26 37 4248 4259 O

must 0 4 4260 4264 O
be 5 7 4265 4267 O
recovered 8 17 4268 4277 O
from 18 22 4278 4282 O
a 23 24 4283 4284 O
prior 25 30 4285 4290 B-treatment
major 31 36 4291 4296 I-treatment
surgery 37 44 4297 4304 I-treatment

must 0 4 4305 4309 O
have 5 9 4310 4314 O
failed 10 16 4315 4321 O
prior 17 22 4322 4327 B-treatment
standard 23 31 4328 4336 I-treatment
curative 32 40 4337 4345 I-treatment
chemotherapy 41 53 4346 4358 I-treatment
for 54 57 4359 4362 O
their 58 63 4363 4368 O
disease 64 71 4369 4376 O

must 0 4 4377 4381 O
have 5 9 4382 4386 O
histologically 10 24 4387 4401 O
or 25 27 4402 4404 O
cytologically 28 41 4405 4418 O
confirmed 42 51 4419 4428 O
malignant 52 61 4429 4438 B-cancer
neoplasms 62 71 4439 4448 I-cancer
( 72 73 4449 4450 O
not 73 76 4450 4453 O
including 77 86 4454 4463 O
hematological 87 100 4464 4477 B-cancer
malignancies 101 113 4478 4490 I-cancer
and 114 117 4491 4494 O
brain 118 123 4495 4500 B-cancer
tumors 124 130 4501 4507 I-cancer
) 130 131 4507 4508 O
untreated 132 141 4509 4518 O
or 142 144 4519 4521 O
previously 145 155 4522 4532 O
treated 156 163 4533 4540 O
requiring 164 173 4541 4550 O
further 174 181 4551 4558 O
treatment 182 191 4559 4568 B-treatment

must 0 4 4569 4573 O
have 5 9 4574 4578 O
measurable 10 20 4579 4589 B-chronic_disease
disease 21 28 4590 4597 I-chronic_disease
( 29 30 4598 4599 O
Response 30 38 4599 4607 O
Evaluation 39 49 4608 4618 O
Criteria 50 58 4619 4627 O
in 59 61 4628 4630 O
Solid 62 67 4631 4636 O
Tumors 68 74 4637 4643 O
[ 75 76 4644 4645 O
RECIST 76 82 4645 4651 O
] 82 83 4651 4652 O
1.1 84 87 4653 4656 O
) 87 88 4656 4657 O

or 0 2 4658 4660 O
Arm 3 6 4661 4664 O
C 7 8 4665 4666 O
( 9 10 4667 4668 O
eribulin 10 18 4668 4676 B-treatment
) 18 19 4676 4677 O
expansion 20 29 4678 4687 O
cohort 30 36 4688 4694 O
, 36 37 4694 4695 O
patients 38 46 4696 4704 O
must 47 51 4705 4709 O
have 52 56 4710 4714 O
triple 57 63 4715 4721 B-cancer
negative 64 72 4722 4730 I-cancer
breast 73 79 4731 4737 I-cancer
cancer 80 86 4738 4744 I-cancer
( 87 88 4745 4746 O
eribulin 88 96 4746 4754 O
naive 97 102 4755 4760 O
) 102 103 4760 4761 O

primary 0 7 4762 4769 O
central 8 15 4770 4777 B-cancer
nervous 16 23 4778 4785 I-cancer
system 24 30 4786 4792 I-cancer
( 31 32 4793 4794 I-cancer
CNS 32 35 4794 4797 I-cancer
) 35 36 4797 4798 I-cancer
tumor 37 42 4799 4804 I-cancer
or 43 45 4805 4807 O
CNS 46 49 4808 4811 B-cancer
tumor 50 55 4812 4817 I-cancer
involvement 56 67 4818 4829 O

recovered 0 9 4830 4839 O
to 10 12 4840 4842 O
grade 13 18 4843 4848 O
= 19 20 4849 4850 O
< 20 21 4850 4851 O
1 22 23 4852 4853 B-upper_bound
by 24 26 4854 4856 O
the 27 30 4857 4860 O
National 31 39 4861 4869 B-clinical_variable
Cancer 40 46 4870 4876 I-clinical_variable
Institute 47 56 4877 4886 I-clinical_variable
Common 57 63 4887 4893 I-clinical_variable
Terminology 64 75 4894 4905 I-clinical_variable
Criteria 76 84 4906 4914 I-clinical_variable
for 85 88 4915 4918 I-clinical_variable
Adverse 89 96 4919 4926 I-clinical_variable
Events 97 103 4927 4933 I-clinical_variable
, 103 104 4933 4934 O
version 105 112 4935 4942 O
4.03 113 117 4943 4947 O
( 118 119 4948 4949 O
NCI 119 122 4949 4952 O
- 122 123 4952 4953 O
CTCAE 123 128 4953 4958 O
v4.03 129 134 4959 4964 O
) 134 135 4964 4965 O
from 136 140 4966 4970 O
the 141 144 4971 4974 O
effects 145 152 4975 4982 O
of 153 155 4983 4985 O
recent 156 162 4986 4992 B-treatment
surgery 163 170 4993 5000 I-treatment
, 170 171 5000 5001 O
radiotherapy 172 184 5002 5014 B-treatment
, 184 185 5014 5015 O
chemotherapy 186 198 5016 5028 B-treatment
, 198 199 5028 5029 O
hormonal 200 208 5030 5038 B-treatment
therapy 209 216 5039 5046 I-treatment
, 216 217 5046 5047 O
or 218 220 5048 5050 O
other 221 226 5051 5056 O
targeted 227 235 5057 5065 B-treatment
therapies 236 245 5066 5075 I-treatment
, 245 246 5075 5076 O
with 247 251 5077 5081 O
the 252 255 5082 5085 O
exception 256 265 5086 5095 O
of 266 268 5096 5098 O
alopecia 269 277 5099 5107 B-chronic_disease

subjects 0 8 5108 5116 O
must 9 13 5117 5121 O
have 14 18 5122 5126 O
failed 19 25 5127 5133 O
, 25 26 5133 5134 O
be 27 29 5135 5137 O
intolerant 30 40 5138 5148 O
to 41 43 5149 5151 O
, 43 44 5151 5152 O
or 45 47 5153 5155 O
be 48 50 5156 5158 O
ineligible 51 61 5159 5169 O
for 62 65 5170 5173 O
any 66 69 5174 5177 O
potentially 70 81 5178 5189 O
curative 82 90 5190 5198 O
approved 91 99 5199 5207 O
treatment 100 109 5208 5217 B-treatment
, 109 110 5217 5218 O
irrespective 111 123 5219 5231 O
of 124 126 5232 5234 O
line 127 131 5235 5239 O
of 132 134 5240 5242 O
therapy 135 142 5243 5250 B-treatment

subjects 0 8 5251 5259 O
receiving 9 18 5260 5269 O
chronic 19 26 5270 5277 B-treatment
systemic 27 35 5278 5286 I-treatment
steroid 36 43 5287 5294 I-treatment
therapy 44 51 5295 5302 I-treatment
( 52 53 5303 5304 O
in 53 55 5304 5306 O
dosing 56 62 5307 5313 O
exceeding 63 72 5314 5323 B-upper_bound
10 73 75 5324 5326 I-upper_bound
mg 76 78 5327 5329 I-upper_bound
daily 79 84 5330 5335 O
of 85 87 5336 5338 O
prednisone 88 98 5339 5349 B-treatment
equivalent 99 109 5350 5360 O
) 109 110 5360 5361 O
or 111 113 5362 5364 O
other 114 119 5365 5370 O
form 120 124 5371 5375 O
of 125 127 5376 5378 O
immunosuppressive 128 145 5379 5396 B-treatment
therapy 146 153 5397 5404 I-treatment
within 154 160 5405 5411 O
7 161 162 5412 5413 B-upper_bound
days 163 167 5414 5418 I-upper_bound
before 168 174 5419 5425 I-upper_bound
the 175 178 5426 5429 O
first 179 184 5430 5435 O
dose 185 189 5436 5440 O
of 190 192 5441 5443 O
study 193 198 5444 5449 O
treatment 199 208 5450 5459 B-treatment

subjects 0 8 5460 5468 O
with 9 13 5469 5473 O
an 14 16 5474 5476 O
active 17 23 5477 5483 O
, 23 24 5483 5484 O
known 25 30 5485 5490 O
or 31 33 5491 5493 O
suspected 34 43 5494 5503 O
autoimmune 44 54 5504 5514 B-chronic_disease
disease 55 62 5515 5522 I-chronic_disease

the 0 3 5523 5526 O
major 4 9 5527 5532 B-treatment
surgery 10 17 5533 5540 I-treatment
must 18 22 5541 5545 O
be 23 25 5546 5548 O
performed 26 35 5549 5558 O
at 36 38 5559 5561 O
least 39 44 5562 5567 O
4 45 46 5568 5569 B-lower_bound
weeks 47 52 5570 5575 I-lower_bound
prior 53 58 5576 5581 I-lower_bound
to 59 61 5582 5584 O
consent 62 69 5585 5592 O
date 70 74 5593 5597 O

